Cargando…

The clinical application of critical flicker fusion frequency in demyelinating optic neuritis

PURPOSE: To investigate the application of critical flicker fusion frequency (CFF) in demyelinating optic neuritis (DON). METHODS: A cross-sectional study. A total of 127 eyes in 69 DON patients and 63 eyes in 33 healthy control (HC) groups were included between January 2021 to September 2021 from D...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Junxia, Wang, Yongping, Tan, Shaoying, Xu, Guangcan, Zhou, Huanfen, Xu, Quangang, Wei, Shihui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577832/
https://www.ncbi.nlm.nih.gov/pubmed/37846319
http://dx.doi.org/10.1016/j.aopr.2021.100011
_version_ 1785121392796106752
author Fu, Junxia
Wang, Yongping
Tan, Shaoying
Xu, Guangcan
Zhou, Huanfen
Xu, Quangang
Wei, Shihui
author_facet Fu, Junxia
Wang, Yongping
Tan, Shaoying
Xu, Guangcan
Zhou, Huanfen
Xu, Quangang
Wei, Shihui
author_sort Fu, Junxia
collection PubMed
description PURPOSE: To investigate the application of critical flicker fusion frequency (CFF) in demyelinating optic neuritis (DON). METHODS: A cross-sectional study. A total of 127 eyes in 69 DON patients and 63 eyes in 33 healthy control (HC) groups were included between January 2021 to September 2021 from Department of Ophthalmology, PLA General Hospital. Patients underwent best-corrected visual acuity (BCVA), visual field, optical coherence tomography (OCT), flash visual evoked potential (F-VEP), and CFF examinations. The affected eyes were divided into aquaporins 4 (AQP4-), myelin oligodendrocyte glycoprotein (MOG-), and double negative DON according to serum antibody; mild, moderate, severe degree visual impairment according to BCVA ≥ 0.5, 0.1-0.5, < 0.1; and 4 groups: < 1, 1 ∼< 3, 3 ∼ < 6 and > 6 months according to time interval from onset to CFF examination. One-way ANOVA was used to perform above subgroup analysis. The correlations between CFF and F-VEP peak time, peak value, BCVA and mean visual filed defect (MD) were analyzed in order via Pearson correlation analysis. RESULTS: he trichromatic values of red, green, and yellow in DON affected eyes were 21.83 ± 9.03, 23.66 ± 10.21, 24.09 ± 10.77 Hz, respectively, which was significantly reduced compared with the HC group (t = -14.82, -14.22, -14.00; P < 0.001). The subgroup analysis showed no significant difference between different antibody subtypes (P = 0.914 <0.848 <0.604), whereas, a significant decrease of CFF trichromatic value was found in severe visual acuity impairment group (P < 0.001). There was a significant difference in CFF- trichromatic values at different time points (P < 0.001), to be specific, CFF fluctuated under 20Hz within 3 months after onset and tended to be stable around 24-28Hz. Correlation analysis showed that the peak time of F-VEP (r = -0.486, -0.515, -0.526; P < 0.001), BVCA (r = -0.640, -0.659, -0.642; P < 0.001), were negatively correlated with CFF trichromatic values, MD and CFF were positively correlated (r = 0.486, 0.453, 0.476; P = 0.003, 0.006, 0.004). CONCLUSIONS: A significant decrease of CFF value was found in DON-affected eyes, and it has a good correlation with BCVA, MD and latency of F-VEP, and can better reflect the impairment of visual function
format Online
Article
Text
id pubmed-10577832
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-105778322023-10-16 The clinical application of critical flicker fusion frequency in demyelinating optic neuritis Fu, Junxia Wang, Yongping Tan, Shaoying Xu, Guangcan Zhou, Huanfen Xu, Quangang Wei, Shihui Adv Ophthalmol Pract Res Full Length Article PURPOSE: To investigate the application of critical flicker fusion frequency (CFF) in demyelinating optic neuritis (DON). METHODS: A cross-sectional study. A total of 127 eyes in 69 DON patients and 63 eyes in 33 healthy control (HC) groups were included between January 2021 to September 2021 from Department of Ophthalmology, PLA General Hospital. Patients underwent best-corrected visual acuity (BCVA), visual field, optical coherence tomography (OCT), flash visual evoked potential (F-VEP), and CFF examinations. The affected eyes were divided into aquaporins 4 (AQP4-), myelin oligodendrocyte glycoprotein (MOG-), and double negative DON according to serum antibody; mild, moderate, severe degree visual impairment according to BCVA ≥ 0.5, 0.1-0.5, < 0.1; and 4 groups: < 1, 1 ∼< 3, 3 ∼ < 6 and > 6 months according to time interval from onset to CFF examination. One-way ANOVA was used to perform above subgroup analysis. The correlations between CFF and F-VEP peak time, peak value, BCVA and mean visual filed defect (MD) were analyzed in order via Pearson correlation analysis. RESULTS: he trichromatic values of red, green, and yellow in DON affected eyes were 21.83 ± 9.03, 23.66 ± 10.21, 24.09 ± 10.77 Hz, respectively, which was significantly reduced compared with the HC group (t = -14.82, -14.22, -14.00; P < 0.001). The subgroup analysis showed no significant difference between different antibody subtypes (P = 0.914 <0.848 <0.604), whereas, a significant decrease of CFF trichromatic value was found in severe visual acuity impairment group (P < 0.001). There was a significant difference in CFF- trichromatic values at different time points (P < 0.001), to be specific, CFF fluctuated under 20Hz within 3 months after onset and tended to be stable around 24-28Hz. Correlation analysis showed that the peak time of F-VEP (r = -0.486, -0.515, -0.526; P < 0.001), BVCA (r = -0.640, -0.659, -0.642; P < 0.001), were negatively correlated with CFF trichromatic values, MD and CFF were positively correlated (r = 0.486, 0.453, 0.476; P = 0.003, 0.006, 0.004). CONCLUSIONS: A significant decrease of CFF value was found in DON-affected eyes, and it has a good correlation with BCVA, MD and latency of F-VEP, and can better reflect the impairment of visual function Elsevier 2021-11-17 /pmc/articles/PMC10577832/ /pubmed/37846319 http://dx.doi.org/10.1016/j.aopr.2021.100011 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Full Length Article
Fu, Junxia
Wang, Yongping
Tan, Shaoying
Xu, Guangcan
Zhou, Huanfen
Xu, Quangang
Wei, Shihui
The clinical application of critical flicker fusion frequency in demyelinating optic neuritis
title The clinical application of critical flicker fusion frequency in demyelinating optic neuritis
title_full The clinical application of critical flicker fusion frequency in demyelinating optic neuritis
title_fullStr The clinical application of critical flicker fusion frequency in demyelinating optic neuritis
title_full_unstemmed The clinical application of critical flicker fusion frequency in demyelinating optic neuritis
title_short The clinical application of critical flicker fusion frequency in demyelinating optic neuritis
title_sort clinical application of critical flicker fusion frequency in demyelinating optic neuritis
topic Full Length Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577832/
https://www.ncbi.nlm.nih.gov/pubmed/37846319
http://dx.doi.org/10.1016/j.aopr.2021.100011
work_keys_str_mv AT fujunxia theclinicalapplicationofcriticalflickerfusionfrequencyindemyelinatingopticneuritis
AT wangyongping theclinicalapplicationofcriticalflickerfusionfrequencyindemyelinatingopticneuritis
AT tanshaoying theclinicalapplicationofcriticalflickerfusionfrequencyindemyelinatingopticneuritis
AT xuguangcan theclinicalapplicationofcriticalflickerfusionfrequencyindemyelinatingopticneuritis
AT zhouhuanfen theclinicalapplicationofcriticalflickerfusionfrequencyindemyelinatingopticneuritis
AT xuquangang theclinicalapplicationofcriticalflickerfusionfrequencyindemyelinatingopticneuritis
AT weishihui theclinicalapplicationofcriticalflickerfusionfrequencyindemyelinatingopticneuritis
AT fujunxia clinicalapplicationofcriticalflickerfusionfrequencyindemyelinatingopticneuritis
AT wangyongping clinicalapplicationofcriticalflickerfusionfrequencyindemyelinatingopticneuritis
AT tanshaoying clinicalapplicationofcriticalflickerfusionfrequencyindemyelinatingopticneuritis
AT xuguangcan clinicalapplicationofcriticalflickerfusionfrequencyindemyelinatingopticneuritis
AT zhouhuanfen clinicalapplicationofcriticalflickerfusionfrequencyindemyelinatingopticneuritis
AT xuquangang clinicalapplicationofcriticalflickerfusionfrequencyindemyelinatingopticneuritis
AT weishihui clinicalapplicationofcriticalflickerfusionfrequencyindemyelinatingopticneuritis